IBRX Stock Analysis: Price, Trends & Outlook 2026
Explore IBRX stock price, earnings, technical analysis, and forecast. Is IBRX stock a buy? Get balanced insights on ImmunityBio’s valuation and outlook as of March 2026 Introduction ImmunityBio develops cancer immunotherapies and vaccines. It focuses on treatments like Anktiva for bladder cancer. IBRX stock draws attention due to recent earnings beats and biotech momentum. Broader … Read more